STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Lifeloc Technologies Inc SEC Filings

LCTC OTC

Welcome to our dedicated page for Lifeloc Technologies SEC filings (Ticker: LCTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Lifeloc Technologies builds the evidential breathalyzers that keep factory floors, patrol cars and correctional facilities safe—and its SEC disclosures hold the numbers behind that mission. Whether you need the R&D spend driving the SpinDx drug platform or the backlog tied to bulk workplace orders, youll find it in a few clicks here—no 300-page PDF hunt required.

Stock Titans AI engine reads every Lifeloc Technologies quarterly earnings report 10-Q filing, annual report 10-K, and 8-K material event the moment it lands on EDGAR. Our summaries translate complex accounting into plain English, highlight breathalyzer segment margins, and flag any shift in training-service revenue. Turn on real-time alerts to track Lifeloc Technologies Form 4 insider transactions—see exactly when executives buy or sell before product launches. Prefer a deeper dive? Drill straight into the proxy statement to compare executive compensation with peer safety-tech firms, or scan AI-generated redlines that show what changed since last quarter.

  • Lifeloc Technologies insider trading Form 4 transactions with instant email and SMS alerts
  • Lifeloc Technologies annual report 10-K simplified so you grasp risk factors and SpinDx milestones
  • Lifeloc Technologies 8-K material events explained in context—product recalls, patent wins, contract awards
  • understanding Lifeloc Technologies SEC documents with AI—no legal dictionary needed
  • Lifeloc Technologies executive stock transactions Form 4 heat-maps for trend spotting
  • Lifeloc Technologies proxy statement executive compensation breakdown at a glance

From breathalyzer unit sales to capitalized software costs, our platform connects every filing type to the metrics that move LCTCs valuation—saving you hours and letting you act on insights, not PDFs.

Rhea-AI Summary

Lifeloc Technologies, Inc. (LCTC) furnished a press release announcing operating results for the period ended September 30, 2025. The company made the release available on its website on November 12, 2025 and attached it as Exhibit 99.1.

The information was furnished rather than filed, which means it is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless expressly stated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Lifeloc Technologies, Inc. reported Q3 2025 results. Total revenues were $2,257,448, with product sales of $2,241,331 (up 8% year over year). Gross profit was $906,693 (down 1%), reflecting higher costs. The quarter recorded a net loss of $263,439, or $0.10 per share.

For the nine months ended September 30, 2025, revenues were $6,753,858 and net loss was $949,764. Cash and cash equivalents were $685,097 as of September 30, 2025. Current liabilities were $907,861, and the company cited net liquid assets of $641,692. Outstanding debt was approximately $1.8M, including a term loan at 2.95% and subordinated debentures at 8.25%.

The company continues investing in SpinDetect™ development. Subsequent to quarter-end, it entered a merger agreement with Electronic Systems Technology, Inc.; an S‑4/A was filed on October 15, 2025, with closing subject to shareholder and regulatory approvals. Common shares outstanding were 2,752,616 as of November 10, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Lifeloc Technologies (LCTC) announced a merger agreement with Electronic Systems Technology (ELST). A newly formed Lifeloc subsidiary will merge into ELST, and ELST will continue as a wholly owned subsidiary of Lifeloc. ELST shareholders will receive Lifeloc common stock based on an agreed exchange ratio, with cash paid in lieu of fractional shares.

Closing is subject to customary conditions, including ELST shareholder approval, the effectiveness of a Form S-4 registration statement for the shares to be issued, and required regulatory approvals. The agreement includes customary representations, warranties, covenants, termination rights, and conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Lifeloc Technologies (LCTC)?

The current stock price of Lifeloc Technologies (LCTC) is $3.1 as of November 19, 2025.

What is the market cap of Lifeloc Technologies (LCTC)?

The market cap of Lifeloc Technologies (LCTC) is approximately 8.7M.
Lifeloc Technologies Inc

OTC:LCTC

LCTC Rankings

LCTC Stock Data

8.73M
495.23k
82.01%
Scientific & Technical Instruments
Technology
Link
United States
Wheat Ridge